Worsening BP Outcomes Seen in HTN Patients During Pandemic
THURSDAY, Nov. 3, 2022 (HealthDay News) — For individuals with hypertension, worsening blood pressure (BP) outcomes were seen during the first eight months of the COVID-19 pandemic, according to a study published online Nov. 1 in Hypertension.Hiroshi…
Learn MoreExcessive Alcohol Responsible for One in Eight Adult Deaths Before Age 64
THURSDAY, Nov. 3, 2022 (HealthDay News) — One in eight total deaths among U.S. adults aged 20 to 64 years was attributable to excessive alcohol use, according to a study published online Nov. 1 in JAMA Network Open.Marissa B. Esser, Ph.D., from the U…
Learn MorePhysicians Say Faulty Oxygen Devices Put Lives in Peril
THURSDAY, Nov. 3, 2022 (HealthDay News) — Faulty readings by pulse oximeters may have resulted in more COVID-19 deaths among minorities, doctors warned in testimony before a U.S. Food and Drug Administration advisory panel this week.The devices appea…
Learn MoreFrailty-Related Fracture Risk Higher for Seniors With Cancer History
THURSDAY, Nov. 3, 2022 (HealthDay News) — Older adults with a history of cancer have an increased risk for frailty-related bone fracture, according to a study published online Nov. 3 in JAMA Oncology.Erika Rees-Punia, Ph.D., from the American Cancer …
Learn MoreBrentuximab Vedotin + Chemo Ups Event-Free Survival in Peds Hodgkin Lymphoma
THURSDAY, Nov. 3, 2022 (HealthDay News) — For children with high-risk Hodgkin lymphoma, the addition of brentuximab vedotin to standard chemotherapy results in improved three-year event-free survival, with no increase in toxic effects, according to a…
Learn MoreExtra Parenteral Amino Acids No Benefit for Extremely Preterm Infants
THURSDAY, Nov. 3, 2022 (HealthDay News) — For infants with extremely low birthweight, extra parenteral amino acids for five days after birth do not increase survival free from neurodisability at two years, according to a study published in the Nov. 3…
Learn MoreAI Algorithm May ID Dysfunctional Immune Profiles in Acute Infection
THURSDAY, Nov. 3, 2022 (HealthDay News) — A machine learning framework, built to deploy a quantitative sepsis response signature, can identify individuals with dysfunctional immune profiles, according to a study published online Nov. 2 in Science Tra…
Learn MorePrevalence of Benign Prostatic Hyperplasia Increasing Globally
THURSDAY, Nov. 3, 2022 (HealthDay News) — The prevalence of benign prostatic hyperplasia is increasing globally, according to a study published online Oct. 20 in The Lancet Healthy Longevity.Atalel Fentahun Awedew, M.D., from Addis Ababa University i…
Learn MoreSingle-Dose Psilocybin Reduces Depression Scores Over Three Weeks
THURSDAY, Nov. 3, 2022 (HealthDay News) — A single 25-mg dose of psilocybin reduces depression scores significantly more than a 1-mg dose over a three-week period among individuals with treatment-resistant depression, according to a study published i…
Learn MoreGuideline Developed for Diagnosis, Management of Aortic Disease
THURSDAY, Nov. 3, 2022 (HealthDay News) — In a 2022 guideline issued by the American College of Cardiology and the American Heart Association and published online Nov. 2 in Circulation, recommendations are presented for the diagnosis and management o…
Learn More